The Asociación Española Contra el Cáncer has launched ‘Nos lo tomamos a pecho’ to share the experiences of patients and those around them. Spain expects 38,318 new breast cancer cases in 2026.
Breast cancer is Spain’s second most common tumour by incidence. An estimated 38,318 new cases will be diagnosed in 2026, while more than 516,000 women are expected to be living with a diagnosis.
Net survival five years after diagnosis is 87%. Progress in research and prevention has contributed to that figure, as has earlier diagnosis. But survival rates do not capture the support many patients need in everyday life. The Asociación Española Contra el Cáncer says research must be diverse and sustained over time, with the aim of helping more people continue their personal and professional plans.
That gap is the focus of ‘Nos lo tomamos a pecho’, a campaign launched by the Asociación Española Contra el Cáncer. It aims to give patients and people around them a voice, and to show how experiences can differ even when the diagnosis is the same.
María Ferrer-Vidal, a cancer survivor, spoke with Luis Vallés about her experience and the support she needed. Her story follows what she went through until the cancer disappeared. The association’s campaign sets those personal needs against the survival figures. Its breast cancer research work also includes clinical development: the association’s blog has reported the launch of a clinical trial for HER2-positive breast cancer.
RUSSPAIN has also covered other developments in Spain, including the Museo Goya reopening in Zaragoza.
